Trader NoteBIO
Bio-Rad Heads Into Q1 Print With Shorts in Retreat
Bio-Rad Laboratories reports Q1 2026 results after the close tomorrow, April 30. The stock is down 8.6% on the week to $279.34, falling harder than most peers. The setup heading into the print is defined by one clear…
1 min read
